Geographical differences in the use of oral corticosteroids in patients with severe asthma in Spain: heat map based on existing databases analyses

[1] Bousquet J(2005)The public health implications of asthma Bull World Health Organ 83 548-554

[2] Bousquet PJ(2014)International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma Eur Respir J 43 343-373

[3] Godard P(2015)The prevalence of severe refractory asthma J Allergy Clin Immunol 135 896-902

[4] Daures JP(2020)Referral recommendations for adult emergency department patients with exacerbated asthma Emergencias: revista de la Sociedad Espanola de Medicina de Emergencias 32 258-268

[5] Chung KF(2010)Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry Thorax 65 787-794

[6] Wenzel SE(2021)Cluster analysis of inflammatory biomarker expression in the international severe asthma registry J Allergy Clin Immunol Pract 9 2680-8.e7

[7] Brozek JL(2020)Expert consensus on the tapering of oral corticosteroids for the treatment of asthma: a Delphi study Am J Resp Crit Care Med 203 871-204

[8] Bush A(2018)Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study J Asthma Allergy 11 193-6.e7

[9] Castro M(2018)Oral corticosteroid exposure and adverse effects in asthmatic patients J Allergy Clin Immunol 141 110-847

[10] Sterk PJ(2016)Dose-response relationship between long-term systemic corticosteroid use and related complications in patients with severe asthma J Manag Care Spec Pharm 22 833-293

[1] Bousquet J(2005)The public health implications of asthma Bull World Health Organ 83 548-554

[2] Bousquet PJ(2014)International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma Eur Respir J 43 343-373

[3] Godard P(2015)The prevalence of severe refractory asthma J Allergy Clin Immunol 135 896-902

[4] Daures JP(2020)Referral recommendations for adult emergency department patients with exacerbated asthma Emergencias: revista de la Sociedad Espanola de Medicina de Emergencias 32 258-268

[5] Chung KF(2010)Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry Thorax 65 787-794

[6] Wenzel SE(2021)Cluster analysis of inflammatory biomarker expression in the international severe asthma registry J Allergy Clin Immunol Pract 9 2680-8.e7

[7] Brozek JL(2020)Expert consensus on the tapering of oral corticosteroids for the treatment of asthma: a Delphi study Am J Resp Crit Care Med 203 871-204

[8] Bush A(2018)Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study J Asthma Allergy 11 193-6.e7

[9] Castro M(2018)Oral corticosteroid exposure and adverse effects in asthmatic patients J Allergy Clin Immunol 141 110-847

[10] Sterk PJ(2016)Dose-response relationship between long-term systemic corticosteroid use and related complications in patients with severe asthma J Manag Care Spec Pharm 22 833-293